Abstract
This article describes the effects of dexmedetomidine (DEX) – the active ingredient of medetomidine, which is the latest popular sedative for functional magnetic resonance imaging (fMRI) in rodents – on multiple unit activity, local field potential (LFP), cerebral blood flow (CBF), pial vessel diameter [indicative of cerebral blood volume (CBV)], and blood oxygenation level‐dependent (BOLD)fMRI. These measurements were obtained from the rat somatosensory cortex during 10 s of forepaw stimulation. We found that the continuous intravascular systemic infusion ofDEX(50 μg/kg/h, doses typically used infMRIstudies) caused epileptic activities, and that supplemental isoflurane (ISO) administration of ~0.3% helped to suppress the development of epileptic activities and maintained robust neuronal and hemodynamic responses for up to 3 h. Supplemental administration ofN2Oin addition toDEXnearly abolished hemodynamic responses even if neuronal activity remained. UnderDEX + ISOanesthesia, spike firing rate and the delta power ofLFPincreased, whereas beta and gamma power decreased, as compared withISO‐only anesthesia.DEXadministration caused pial arteries and veins to constrict nearly equally, resulting in decreases in baselineCBFandCBV. EvokedLFPandCBFresponses to forepaw stimulation were largest at a frequency of 8–10 Hz, and a non‐linear relationship was observed. Similarly,BOLD fMRIresponses measured at 9.4 T were largest at a frequency of 10 Hz. Both pial arteries and veins dilated rapidly (artery, 32.2%; vein, 5.8%), and venous diameter returned to baseline slower than arterial diameter. These results will be useful for designing, conducting and interpretingfMRIexperiments underDEXsedation.

This publication has 100 references indexed in Scilit: